Literature DB >> 403136

Long-term studies on rhesus monkeys (Macaca mulatta) immunized against Plasmodium knowlesi.

E J Cabrera, M L Barr, P H Silverman.   

Abstract

Studies carried out on four rhesus monkeys (Macaca mulatta) that had been vaccinated against Plasmodium knowlesi show that the immunized animals were protected against a challenge with a heterologous strain of P. knowlesi. This protection was shown to be present even 4 years after the immunization schedule has been completed. The effect could not be attributed toprevious infections with the parasite, since four control rhesus monkeys that had recovered from one to four challenges with P. knowlesi died when exposed to the heterologous strain. Data obtained from the lymphocyte transformation test and the radioimmunoassay are also presented.

Entities:  

Mesh:

Year:  1977        PMID: 403136      PMCID: PMC421390          DOI: 10.1128/iai.15.2.461-465.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Qualitative analysis of phospholipids isolated from nonviable Plasmodium antigen.

Authors:  R Beckwith; R H Schenkel; P H Silverman
Journal:  Exp Parasitol       Date:  1975-04       Impact factor: 2.011

2.  A NATURALLY ACQUITED QUOTIDIAN-TYPE MALARIA IN MAN TRANSFERABLE TO MONKEYS.

Authors:  W CHIN; P G CONTACOS; G R COATNEY; H R KIMBALL
Journal:  Science       Date:  1965-08-20       Impact factor: 47.728

3.  Immunity to malaria: antigenic variation in chronic infections of Plasmodium knowlesi.

Authors:  K N Brown; I N Brown
Journal:  Nature       Date:  1965-12-25       Impact factor: 49.962

4.  Immunity to malaria. I. Protection against Plasmodium knowlesi shown by monkeys sensitized with drug-suppressed infections or by dead parasites in Freund's adjuvant.

Authors:  K N Brown; I N Brown; L A Hills
Journal:  Exp Parasitol       Date:  1970-10       Impact factor: 2.011

5.  Vaccination of rhesus monkeys against malaria by use of sucrose density gradient fractions of Plasmodium knowlesi antigens.

Authors:  G L Simpson; R H Schenkel; P H Silverman
Journal:  Nature       Date:  1974-02-01       Impact factor: 49.962

6.  Susceptibility of a new world monkey (Aotus trivirgatus) to an old world simian malarial parasite (Plasmodium knowlesi).

Authors:  W A Siddiqui; J V Schnell; S M Richmond-Crum
Journal:  Trans R Soc Trop Med Hyg       Date:  1974       Impact factor: 2.184

7.  Merozoite vaccination against Plasmodium knowlesi malaria.

Authors:  G H Mitchell; G A Butcher; S Cohen
Journal:  Immunology       Date:  1975-08       Impact factor: 7.397

8.  Ultrastructural study of Plasmodium knowlesi antigen used in vaccination of rhesus monkeys.

Authors:  C A Speer; P H Silverman; M L Barr
Journal:  J Protozool       Date:  1976-08

9.  Vaccination of Rhesus monkeys (Macaca mulatta) against Plasmodium knowlesi by the use of nonviable antigen.

Authors:  R H Schenkel; G L Simpson; P H Silverman
Journal:  Bull World Health Organ       Date:  1973-05       Impact factor: 9.408

  9 in total
  5 in total

1.  Recent advances in applied malaria immunology.

Authors:  C A Speer; P H Silverman
Journal:  Z Parasitenkd       Date:  1979-11

2.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

3.  Host defenses in murine malaria: induction of a protracted state of immunity with a formalin-killed Plasmodium berghei blood parasite vaccine.

Authors:  J R Murphy; M J Lefford
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

Review 4.  Acquired immunity to malaria.

Authors:  Denise L Doolan; Carlota Dobaño; J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

5.  A perspective on malaria vaccines.

Authors:  R S Desowitz; L H Miller
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.